Description
Ectosteric inhibitors of cathepsin K: their mechanism and in vivo efficacy
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-04-01$956,250
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-04-01(start date) | $956,250 | — | Ectosteric inhibitors of cathepsin K: their mechanism and in vivo efficacy |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 110_2020_2021_Q2_6024 | Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada · Discovery Research | $5,760 | FY2021 |
| 110_2019_2020_Q1_2567 | Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada · Discovery Research | $216,000 | FY2020 |
| 110_2018_2019_Q1_4224 | Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada · Research Partnerships | $359,850 | FY2019 |
| 236-2018-2019-Q1-00289 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $359,850 | FY2019 |
| 236-2017-2018-Q4-00762 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $1,400,000 | FY2018 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q4-00438 · retrieved 2026-11-14.